Unwrap.Fund
Unwrap both →
Fund comparison · from official SEC filings

FBT vs TBXU: how much do they overlap?

First Trust NYSE Arca Biotechnology Index Fund and Direxion Daily Biotech Top 5 Bull 2X ETF
Holdings overlap
18%
of assets, by weight
Shared positions
5
of 32 / 9 holdings
FBT expense ratio
0.55%
net, per year
TBXU expense ratio
0.97%
net, per year
Shared holdings
Company
FBT
TBXU
A
ARGXARGENX SE - ADR
3.29%
10.26%
R
REGNREGENERON PHARMACEUTICALS
3.44%
8.69%
A
AMGNAMGEN INC
3.83%
8.68%
V
VRTXVERTEX PHARMACEUTICALS INC
3.42%
8.36%
G
GILDGILEAD SCIENCES INC
4.09%
8.28%
Only in FBT
M
MRNAMODERNA INC
5.26%
U
UTHRUNITED THERAPEUTICS CORP
4.36%
A
ALKSALKERMES PLC
4.23%
A
AXSMAXSOME THERAPEUTICS INC
3.88%
C
CORTCORCEPT THERAPEUTICS INC
3.82%
K
KRYSKRYSTAL BIOTECH INC
3.51%
B
BIIBBIOGEN INC
3.47%
E
EXELEXELIXIS INC
3.46%
N
NBIXNEUROCRINE BIOSCIENCES INC
3.44%
B
BMRNBIOMARIN PHARMACEUTICAL INC
3.40%
S
SRPTSAREPTA THERAPEUTICS INC
3.24%
H
HALOHALOZYME THERAPEUTICS INC
3.17%
B
BNTXBIONTECH SE-ADR
3.16%
I
INCYINCYTE CORP
3.13%
O
ONCBEONE MEDICINES LTD-ADR
3.12%
I
ILMNILLUMINA INC
3.10%
N
NTRANATERA INC
3.03%
A
ACAACADIA PHARMACEUTICALS INC
2.95%
A
ALNYALNYLAM PHARMACEUTICALS INC
2.95%
T
TECHBIO-TECHNE CORP
2.82%
G
GMABGENMAB A/S -SP ADR
2.78%
V
VCYTVERACYTE INC
2.72%
R
RGENREPLIGEN CORP
2.51%
B
BRKRBRUKER CORP
2.35%
N
NEONEOGENOMICS INC
2.00%
Only in TBXU
?
—DREYFUS GOVERNMENT CASH MANAGE
30.53%
?
—GOLDMAN FINANCIAL
25.97%
?
—GOLDMAN SACHS LIQ ES FD A
5.51%
?
—N/A
-6.28%
Hold FBT and TBXU together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Other comparisons you might like
FBT vs IBBiShares Biotechnology ETF
40% overlap
TBXU vs BBHVanEck Biotech ETF
38% overlap
FBT vs IBBQInvesco Nasdaq Biotechnology ETF
34% overlap
FBT vs BIBProShares Ultra Nasdaq Biotechnology
31% overlap
TBXU vs HCMTDirexion HCM Tactical Enhanced US ETF
30% overlap
TBXU vs IBBQInvesco Nasdaq Biotechnology ETF
24% overlap
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.